<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>Tokyo</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>11419</JournalID>
      <JournalPrintISSN>1860-8965</JournalPrintISSN>
      <JournalElectronicISSN>1860-8973</JournalElectronicISSN>
      <JournalTitle>Forensic Toxicology</JournalTitle>
      <JournalAbbreviatedTitle>Forensic Toxicol</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Type="Secondary">Medicinal Chemistry</JournalSubject>
        <JournalSubject Type="Secondary">Medicine/Public Health, general</JournalSubject>
        <JournalSubject Type="Secondary">Forensic Medicine</JournalSubject>
        <JournalSubject Type="Secondary">Medical Law</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>24</VolumeIDStart>
        <VolumeIDEnd>24</VolumeIDEnd>
        <VolumeIssueCount>2</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>8</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2006</Year>
              <Month>7</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>Japanese Association of Forensic Toxicology and Springer-Verlag Tokyo</CopyrightHolderName>
            <CopyrightYear>2006</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art7">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>7</ArticleID>
            <ArticleDOI>10.1007/s11419-006-0007-1</ArticleDOI>
            <ArticleSequenceNumber>7</ArticleSequenceNumber>
            <ArticleTitle Language="En">Conversion of γ-hydroxybutyric acid to a fluorescent derivative: a method for screening</ArticleTitle>
            <ArticleCategory>Original Article</ArticleCategory>
            <ArticleFirstPage>41</ArticleFirstPage>
            <ArticleLastPage>47</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2006</Year>
                <Month>6</Month>
                <Day>15</Day>
              </RegistrationDate>
              <Received>
                <Year>2006</Year>
                <Month>1</Month>
                <Day>10</Day>
              </Received>
              <Accepted>
                <Year>2006</Year>
                <Month>5</Month>
                <Day>17</Day>
              </Accepted>
              <OnlineDate>
                <Year>2006</Year>
                <Month>6</Month>
                <Day>17</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>Japanese Association of Forensic Toxicology and Springer-Verlag Tokyo</CopyrightHolderName>
              <CopyrightYear>2006</CopyrightYear>
            </ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Kumi</GivenName>
                  <FamilyName>Matsuda</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Naoyuki</GivenName>
                  <FamilyName>Asakawa</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Megumi</GivenName>
                  <FamilyName>Iwanaga</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Akinaga</GivenName>
                  <FamilyName>Gohda</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Sunao</GivenName>
                  <FamilyName>Fukushima</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yuji</GivenName>
                  <FamilyName>Ishii</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Hideyuki</GivenName>
                  <FamilyName>Yamada</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>yamada@xenoba.phar.kyushu-u.ac.jp</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Graduate School of Pharmaceutical Sciences</OrgDivision>
                <OrgName>Kyushu University</OrgName>
                <OrgAddress>
                  <Street>3-1-1 Maidashi, Higashi-ku</Street>
                  <City>Fukuoka</City>
                  <Postcode>812-8582</Postcode>
                  <Country Code="JP">Japan</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Forensic Science Laboratory</OrgDivision>
                <OrgName>Fukuoka Prefectural Police HQ</OrgName>
                <OrgAddress>
                  <City>Fukuoka</City>
                  <Country Code="JP">Japan</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Conversion of γ-hydroxybutyric acid (GHB) to a fluorescent derivative using 3-bromomethyl-6,7-dimethoxy-1-methyl-1,2-dihydroquinoxaline-2-one (Br-DMEQ), and its application to drug screening were studied. Br-DMEQ reacted with the carboxyl group of sodium GHB in the presence of a potassium salt and crown ether to produce a fluorescent derivative, which could be easily detected by thin-layer chromatography (TLC). An electrospray ionization mass spectrum of the fluorogenic product supported the expected structure. The Br-DMEQ-derivatized GHB gave an Rf value of 0.49 on TLC, which was easily distinguished from 19 other carboxylic acids; all of the latter had Rf values over 0.61. Various sodium carboxylates including sodium GHB reacted with Br-DMEQ in the presence of KCl, but the free forms of the carboxylic acids did not react under these conditions. When aqueous solution containing GHB was pretreated with sulfuric acid, GHB was converted to γ-butyrolactone, resulting in removal of its reactivity with Br-DMEQ. By such analysis following the derivatization, with and without the above pre-treatment with sulfuric acid, GHB added to human urine could be specifically detected, although the limit of detection was about 100μg/ml, which was 20 times higher than the endogenous blood GHB level. Therefore, the present method seems useful for screening GHB present in a solid state such as powder and tablets, and also in urine samples obtained in overdose cases.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>γ-Hydroxybutyric acid</Keyword>
              <Keyword>Br-DMEQ</Keyword>
              <Keyword>Thin-layer chromatography</Keyword>
              <Keyword>Fluorescent derivative</Keyword>
              <Keyword>Urine</Keyword>
            </KeywordGroup>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/11419_2006_Article_7.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.L.</Initials>
                    <FamilyName>Nicholson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.L.</Initials>
                    <FamilyName>Balster</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">GHB: a new and novel drug of abuse</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>22</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11297827</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXisF2rsLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0376-8716(00)00191-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nicholson KL, Balster RL (2001) GHB: a new and novel drug of abuse. Drug Alcohol Depend 63:1–22</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F.J.</Initials>
                    <FamilyName>Couper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.K.</Initials>
                    <FamilyName>Logan</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Determination of γ-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry</ArticleTitle>
                  <JournalTitle>J Anal Toxicol</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>7</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10654561</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntFGisQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Couper FJ, Logan BK (2000) Determination of γ-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry. J Anal Toxicol 24:1–7</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.G.</Initials>
                    <FamilyName>Wong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.M.</Initials>
                    <FamilyName>Gibson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.C.</Initials>
                    <FamilyName>Snead</FamilyName>
                    <Suffix>3rd</Suffix>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">From the street to the brain: neurobiology of the recreational drug γ-hydroxybutyric acid</ArticleTitle>
                  <JournalTitle>Trends Pharmcol Sci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>34</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtFehsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.tips.2003.11.001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wong CG, Gibson KM, Snead OC 3rd (2004) From the street to the brain: neurobiology of the recreational drug γ-hydroxybutyric acid. Trends Pharmcol Sci 25:29–34</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.D.</Initials>
                    <FamilyName>Ferrara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Zotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Tedeschi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Frison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Castagna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Gallimberti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.L.</Initials>
                    <FamilyName>Gessa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Palatini</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Pharmacokinetics of γ-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses</ArticleTitle>
                  <JournalTitle>Br J Clin Pharmacol</JournalTitle>
                  <VolumeID>34</VolumeID>
                  <FirstPage>231</FirstPage>
                  <LastPage>235</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1389947</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:ByyD3c3htlc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, Gessa GL, Palatini P (1992) Pharmacokinetics of γ-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol 34:231–235</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Palatini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Tedeschi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Frison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Padrini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Zordan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Orlando</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Gallimberti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.L.</Initials>
                    <FamilyName>Gessa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.D.</Initials>
                    <FamilyName>Ferrara</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Dose-dependent absorption and elimination of gammahydroxybutyric acid in healthy volunteers</ArticleTitle>
                  <JournalTitle>Eur J Clin Pharmacol</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>353</FirstPage>
                  <LastPage>356</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8299669</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXpvFWmsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF00265954</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, Ferrara SD (1993) Dose-dependent absorption and elimination of gammahydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 45:353–356</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.V.</Initials>
                    <FamilyName>Kavanagh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Kenny</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Feely</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The urinary excretion of γ-hydroxybutyric acid in man</ArticleTitle>
                  <JournalTitle>J Pharm Pharmacol</JournalTitle>
                  <VolumeID>53</VolumeID>
                  <FirstPage>399</FirstPage>
                  <LastPage>402</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11291756</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXisVCkur4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1211/0022357011775460</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kavanagh PV, Kenny P, Feely J (2001) The urinary excretion of γ-hydroxybutyric acid in man. J Pharm Pharmacol 53:399–402</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.D.</Initials>
                    <FamilyName>Ferrara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Tedeschi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Frison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Castagna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Gallimberti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Giorgetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.L.</Initials>
                    <FamilyName>Gessa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Palatini</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Therapeutic gammahydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry</ArticleTitle>
                  <JournalTitle>J Pharm Biomed Anal</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>483</FirstPage>
                  <LastPage>487</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8399519</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXltlWktro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0731-7085(93)80161-S</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ferrara SD, Tedeschi L, Frison G, Castagna F, Gallimberti L, Giorgetti R, Gessa GL, Palatini P (1993) Therapeutic gammahydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry. J Pharm Biomed Anal 11:483–487</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Yamaguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Hara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Matsunaga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">3-Bromomethyl-6,7-dimethoxy-1-methyl-2(1H)-quinoxalinone as a new fluorescence derivatization reagent for carboxylic acids in high-performance liquid chromatography</ArticleTitle>
                  <JournalTitle>J Chromatogr</JournalTitle>
                  <VolumeID>346</VolumeID>
                  <FirstPage>227</FirstPage>
                  <LastPage>236</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XhtVWlt78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0021-9673(00)90508-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yamaguchi M, Hara S, Matsunaga R, Nakamura M (1985) 3-Bromomethyl-6,7-dimethoxy-1-methyl-2(1H)-quinoxalinone as a new fluorescence derivatization reagent for carboxylic acids in high-performance liquid chromatography. J Chromatogr 346:227–236</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Yamaguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Matsunaga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Fukuda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Ohkura</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Highly sensitive determination of free polyunsaturated, long-chain fatty acids in human serum by high-performance liquid chromatography with fluorescence detection</ArticleTitle>
                  <JournalTitle>Anal Biochem</JournalTitle>
                  <VolumeID>155</VolumeID>
                  <FirstPage>256</FirstPage>
                  <LastPage>261</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3728978</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28Xktlynu7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0003-2697(86)90434-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yamaguchi M, Matsunaga R, Fukuda K, Nakamura M, Ohkura Y (1986) Highly sensitive determination of free polyunsaturated, long-chain fatty acids in human serum by high-performance liquid chromatography with fluorescence detection. Anal Biochem 155:256–261</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.A.</Initials>
                    <FamilyName>Elian</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood</ArticleTitle>
                  <JournalTitle>Forensic Sci Int</JournalTitle>
                  <VolumeID>128</VolumeID>
                  <FirstPage>120</FirstPage>
                  <LastPage>122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12175790</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmtlertrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0379-0738(02)00183-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Elian AA (2002) Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci Int 128:120–122</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
